Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.57 per share a year ago.

CAMBRIDGE, Mass., March 06, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...

Intending to catch a chicken for his dinner, little Henery the Chicken Hawk ventures onto the farm of the eternally feuding Foghorn Leghorn and barnyard dog. Foghorn tries to dump a load of concrete ...

People being 'driven to distraction' by a lighthouse foghorn sounding off has been offered a chance for some respite from the noise. Residents near Land's End have been advised to invest in ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...